terminalia sericea extract
silver cluster-leaf extract
Identification
| Name | terminalia sericea extract |
| IUPAC | terminalia sericea extract |
| CAS Number | 90131-49-0 |
| FDA UNII | Search |
Regulatory
Physical Properties
| Food Chemicals Codex Listed | No |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | information only not used for fragrances or flavors |
| Recommendation for terminalia sericea extract usage levels up to | not for fragrance use. |
| Recommendation for terminalia sericea extract flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
silver cluster-leaf extract
terminalia argentea extract
PubMed:
Antimicrobial evaluation of plants used for the treatment of diarrhoea in a rural community in northern Maputaland, KwaZulu-Natal, South Africa.
PubMed:
Effect of four medicinal plants on amyloid-β induced neurotoxicity in SH-SY5Y cells.
PubMed:
Anti-Proteus activity of some South African medicinal plants: their potential for the prevention of rheumatoid arthritis.
PubMed:
Antimicrobial activity of southern African medicinal plants with dermatological relevance: From an ethnopharmacological screening approach, to combination studies and the isolation of a bioactive compound.
PubMed:
Antidiabetic activity of Terminalia sericea constituents.
PubMed:
In vivo antifungal effect of Combretum and Terminalia species extracts on cutaneous wound healing in immunosuppressed rats.
PubMed:
The use of a rat model to evaluate the in vivo toxicity and wound healing activity of selected Combretum and Terminalia (Combretaceae) species extracts.
PubMed:
In vitro anti-HIV-1 properties of ethnobotanically selected South African plants used in the treatment of sexually transmitted diseases.
PubMed:
Isolation of a stilbene glycoside and other constituents of Terminalia sericeae.
PubMed:
Anolignan B: a bioactive compound from the roots of Terminalia sericea.
PubMed:
Some pharmacological properties of extracts of Terminalia sericea roots.
PubMed:
Antimicrobial activity, toxicity and the isolation of a bioactive compound from plants used to treat sexually transmitted diseases.
PubMed:
Complex formation of sericoside with hydrophilic cyclodextrins: improvement of solubility and skin penetration in topical emulsion based formulations.
PubMed:
Ethnobotanical and antimicrobial investigation on some species of Terminalia and Combretum (Combretaceae) growing in Tanzania.